-
Something wrong with this record ?
Serum redox markers in uncomplicated type 2 diabetes mellitus accompanied with abnormal iron levels
M. Angelovski, M. Spirovska, A. Nikodinovski, A. Stamatoski, D. Atanasov, M. Mladenov, N. Hadzi-Petrushev
Language English Country Czech Republic
Document type Journal Article
Digital library NLK
Source
NLK
Free Medical Journals
from 2004
ProQuest Central
from 2009-03-01 to 6 months ago
Medline Complete (EBSCOhost)
from 2006-03-01 to 6 months ago
Nursing & Allied Health Database (ProQuest)
from 2009-03-01 to 6 months ago
Health & Medicine (ProQuest)
from 2009-03-01 to 6 months ago
Public Health Database (ProQuest)
from 2009-03-01 to 6 months ago
ROAD: Directory of Open Access Scholarly Resources
from 1993
PubMed
37451247
DOI
10.21101/cejph.a7399
Knihovny.cz E-resources
- MeSH
- Antioxidants * metabolism MeSH
- Bilirubin metabolism MeSH
- Biomarkers MeSH
- Diabetes Mellitus, Type 2 * complications MeSH
- Glycated Hemoglobin MeSH
- Uric Acid MeSH
- Humans MeSH
- Oxidation-Reduction MeSH
- Oxidative Stress MeSH
- Advanced Oxidation Protein Products metabolism MeSH
- Thyrotropin metabolism MeSH
- Iron MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
OBJECTIVES: This study aimed at evaluating the serum redox status in type 2 diabetes mellitus (T2DM) accompanied with an imbalance in iron concentrations. METHODS: Diabetic patients were grouped according to serum iron levels [normal (DNFe), low (DLFe), and high (DHFe)], and their clinical and redox parameters [total sulfhydryl groups (tSH), uric acid (UA), and total bilirubin (tBILI) as non-enzymatic antioxidants, and malondialdehyde (MDA) and advanced oxidation products of proteins (AOPP) as markers of oxidative stress] were determined. RESULTS: Glucose and HbA1c levels in the T2DM patients did not differ in function of serum iron. T2DM was associated with reduced tSH levels. In the diabetic patients, tSH, UA, and tBILI negatively correlated with MDA, as well as HbA1c with UA. Accordingly, AOPP and MDA were higher in the diabetic groups compared to the controls. The reduced antioxidant capacity was particularly pronounced in the DLFe group, which was further characterized by lower levels of UA and tBILI compared to the other groups. Subsequently, the level of MDA in the DLFe group was higher compared to the DNFe and DHFe groups. The positive correlation between serum iron levels and the antioxidants UA and tBILI, in conjunction with the negative correlation between serum iron levels and the markers of oxidative stress in the diabetic patients, corroborated the indication that comparatively higher level of oxidative stress is present when T2DM coexists with decreased iron levels. CONCLUSIONS: T2DM-associated redox imbalance is characterized by a decrease in serum total sulfhydryl groups and low serum iron-associated reduction in uric acid and total bilirubin levels, accompanied by increased oxidative stress markers. The relatively noninvasive and simple determination of these parameters may be of considerable interest in monitoring the pathophysiological processes in T2DM patients, and may provide useful insights into the effects of potential therapeutic or nutritional interventions.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23012402
- 003
- CZ-PrNML
- 005
- 20230823152053.0
- 007
- ta
- 008
- 230804s2023 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21101/cejph.a7399 $2 doi
- 035 __
- $a (PubMed)37451247
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Angelovski, Marija $u Department of Physiology, Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, Skopje, Republic of Macedonia
- 245 10
- $a Serum redox markers in uncomplicated type 2 diabetes mellitus accompanied with abnormal iron levels / $c M. Angelovski, M. Spirovska, A. Nikodinovski, A. Stamatoski, D. Atanasov, M. Mladenov, N. Hadzi-Petrushev
- 520 9_
- $a OBJECTIVES: This study aimed at evaluating the serum redox status in type 2 diabetes mellitus (T2DM) accompanied with an imbalance in iron concentrations. METHODS: Diabetic patients were grouped according to serum iron levels [normal (DNFe), low (DLFe), and high (DHFe)], and their clinical and redox parameters [total sulfhydryl groups (tSH), uric acid (UA), and total bilirubin (tBILI) as non-enzymatic antioxidants, and malondialdehyde (MDA) and advanced oxidation products of proteins (AOPP) as markers of oxidative stress] were determined. RESULTS: Glucose and HbA1c levels in the T2DM patients did not differ in function of serum iron. T2DM was associated with reduced tSH levels. In the diabetic patients, tSH, UA, and tBILI negatively correlated with MDA, as well as HbA1c with UA. Accordingly, AOPP and MDA were higher in the diabetic groups compared to the controls. The reduced antioxidant capacity was particularly pronounced in the DLFe group, which was further characterized by lower levels of UA and tBILI compared to the other groups. Subsequently, the level of MDA in the DLFe group was higher compared to the DNFe and DHFe groups. The positive correlation between serum iron levels and the antioxidants UA and tBILI, in conjunction with the negative correlation between serum iron levels and the markers of oxidative stress in the diabetic patients, corroborated the indication that comparatively higher level of oxidative stress is present when T2DM coexists with decreased iron levels. CONCLUSIONS: T2DM-associated redox imbalance is characterized by a decrease in serum total sulfhydryl groups and low serum iron-associated reduction in uric acid and total bilirubin levels, accompanied by increased oxidative stress markers. The relatively noninvasive and simple determination of these parameters may be of considerable interest in monitoring the pathophysiological processes in T2DM patients, and may provide useful insights into the effects of potential therapeutic or nutritional interventions.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a antioxidancia $x metabolismus $7 D000975
- 650 12
- $a diabetes mellitus 2. typu $x komplikace $7 D003924
- 650 _2
- $a kyselina močová $7 D014527
- 650 _2
- $a glykovaný hemoglobin $7 D006442
- 650 _2
- $a produkty pokročilé oxidace proteinů $x metabolismus $7 D062107
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a oxidační stres $7 D018384
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a železo $7 D007501
- 650 _2
- $a bilirubin $x metabolismus $7 D001663
- 650 _2
- $a thyreotropin $x metabolismus $7 D013972
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Spirovska, Marina $u Department of Physiology, Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, Skopje, Republic of Macedonia
- 700 1_
- $a Nikodinovski, Aleksandar $u Institute for Preclinical and Clinical Pharmacology and Toxicology, Medical Faculty, Ss. Cyril and Methodius University, Skopje, Republic of Macedonia
- 700 1_
- $a Stamatoski, Aleksandar $u University Clinic for Maxillofacial Surgery, Medical Faculty, Ss. Cyril and Methodius University, Skopje, Republic of Macedonia
- 700 1_
- $a Atanasov, Dino $u Department of Physiology, Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, Skopje, Republic of Macedonia
- 700 1_
- $a Mladenov, Mitko $u Department of Physiology, Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, Skopje, Republic of Macedonia
- 700 1_
- $a Hadzi-Petrushev, Nikola $u Department of Physiology, Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, Skopje, Republic of Macedonia
- 773 0_
- $w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 31, č. 2 (2023), s. 133-139
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37451247 $y Pubmed
- 910 __
- $a ABA008 $b B 1829 $c 562 $y p $z 0
- 990 __
- $a 20230804 $b ABA008
- 991 __
- $a 20230823152051 $b ABA008
- 999 __
- $a ok $b bmc $g 1972821 $s 1198671
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 31 $c 2 $d 133-139 $e - $i 1210-7778 $m Central European Journal of Public Health $n Cent. Eur. J. Public Health $x MED00001083
- LZP __
- $b NLK198 $a Pubmed-20230804